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ABSTRACT
Background and the purpose of the study: sepsis is one of the most widespread and lethal 
disease in Intensive Care Units (ICU). Based on pathophisyology of sepsis, it seems that routine 
laboratory tests combined with analysis of pro-inflammatory cytokines plasma levels, help 
clinicians to have more information about disease progress and its correct management. 
Methods: This was a prospective observational study to determine the predictive role of Tumor 
Necrosis Factor alpha (TNF-α), Interleukin (IL)-1β and IL-6 as three main pro-inflammatory 
cytokines and Acute Physiology and Chronic Health Evaluation (APACHE II) and Sequential 
Organ Failure Assessment (SOFA) as two scoring systems in mortality of critically ill patients 
with severe sepsis. Fifty and five patients with criteria of severe sepsis were included in this 
study. An exclusion criterion was post Cardiopulmonary Resuscitation (CPR) status. Cytokines 
(TNF-α, IL-1β and IL-6) were assayed in the first, third and seventh days in blood of patients. 
Results and major conclusion: Among three measured cytokines, sequential levels of TNF-α 
and IL-6 showed significant differences between survivors and nonsurvivors. IL-6 had a good 
correlation with outcome and scoring systems during the period of this study. The areas under 
the receiver operating characteristic (AUROC) curve indicated that APACHE II (0.858, 0.848, 
0.861) and IL-6 (0.797, 0.799, 0.899) had discriminative power in prediction of mortality during 
sequental measured days. Multiple logestic regression analysis identified that evaluation of 
APACHE II and TNF-α in the first day and APACHE II and IL-6 in the third and seventh days 
of severe septic patients are independent outcome predictors. Results of this study suggest that 
IL-6 and APACHE II are useful cytokine and scoring systems respectively in prediction of 
mortality and clinical evaluation of severe septic patients.
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INTRODUCTION
Sepsis is one of the most widespread and lethal disease 
in intensive care units which also charges the health 
system a lot (1). At present, judgment about outcome 
of septic patients and evaluation of treatment is based 
on  clinical  evaluation  and  using  severity  scores 
(2).  It  seems  that  routine  laboratory  and  clinical 
examination do not accurately distinguish severity 
of illness and do not sensitively identify the risk of 
mortality in the septic patients. Recent advances on 
the  immunologic  processes  and  pathophysiology 
of  sepsis  help  to  use  more  sensitive  and  specific 
tools  for  determination  of  severity  of  sepsis  and 
evaluation of disease management (3). Investigators 
have been trying to clarify the role of cytokines in 
various illnesses (4, 5). Extensive releases of various 
inflammatory  mediators  in  response  to  pathogens 
cause catastrophic exacerbation of patients in severe 
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on  the  admission  of  patients  to  the  ICUs.  Blood 
samples were collected in the first, third and seventh 
days after recruitment into the study to determine IL-
1β, IL-6 and TNF-α concentration. The APACHE II 
scores for definition of severity of illness and SOFA 
score as severity of organ failure were calculated in 
the first, third and seventh days of admission. Blood, 
urine and intratracheal cultures were obtained from 
all patients during hospitalization for identification 
of  sepsis  criteria  to  determine  source  and  type 
of  infection  prior  to  initiation  of  antimicrobial 
therapy.  For  optimal  sensitivity  and  specificity, 
blood cultures (aerobic and anaerobic bottles) were 
drawn  from  two  or  three  different  venipuncture 
sites. Standard treatment of sepsis included early goal- 
directed resuscitation, early broad – spectrum antibiotics, 
narrowing  antibiotic  therapy  based  on  microbial 
therapy and clinical data, source control by surgical 
procedures, stress doses of steroids for septic shock, 
maintenance of blood glucose < 150 mg/dl, DVT/
stress  ulcer  prophylaxis,  required  homodynamic 
and ventilatory support were performed for patients 
enrolled in this study. The main outcome was 28-day 
mortality.
Cytokine measurement
Blood samples were collected between 10 and 12 
A.M. using an arterial line for septic patients. Samples 
were centrifuged immediately in ICU at 800 g for 
15 minutes and separated plasma was stored at −80°C. 
Plasma levels of TNF-α, IL-1β and IL-6 were measured 
by  enzyme-linked  immunosorbent  assay  (ELISA) 
with  a  commercial  kit  (Bender  MedSystem  Inc, 
Vienna, Austria) using the manufacture’s protocol. All 
cytokine measurements were performed in a faculty 
laboratory blinded to the clinical data. The samples 
were  assayed  in  duplicates  with  suitable  controls 
provided  by  manufacturer  for  the  construction  of 
standard curves. 
Statistics
Data are presented as mean ± standard error of mean. 
Univariate comparisons of baseline characteristics 
were performed by the independent Student’s t-test 
in  normally  distributed  data  between  two  groups 
(survivors  and  non-survivors)  and  Mann-Whitney 
U test for non- normal data, respectively. Two-way 
analysis of variance was used to compare repeated 
measurements of cytokine levels between survivors 
and nonsurvivors with multiple comparisons 
(Scheffe’s  test)  during  time. A  P  value  less  than 
0.05  was  considered  statistically  significant.  The 
correlations between outcome and the variables are 
reported as Spearman’s rho correlation coefficient 
and  among  variables  as  Pearson’s  correlation 
coefficient. The multivariate analysis was performed 
by multiple logistic regression, using the “backward 
conditional” method for selection of the independent 
variables. The Odds Ratio (OR) of an independent 
sepsis and septic shock. Among cytokines, TNF-α, 
IL-1β and IL-6 play central roles for initiation of the 
innate immune response and propagation of acquired 
immune responses. Exaggerate activation of innate 
immunity with these cytokines can lead to vascular 
collapse, shock, and death (6). Early intervention to 
prevent clinical deterioration is the most important 
step  in  the  successful  management  of  patients 
with  severe  sepsis  (7).  Pursuit  of  management 
is a major obstacle in severe septic patients. The 
clinician should be able to realize the improvement 
of  disease  as  soon  as  possible  in  order  to  refine 
treatment strategy and if it is possible the clinician 
should  be  equipped  with  diagnostic  molecular 
tests which resound pathophysiological events (8). 
Based on previous surveys, the prognostic value of 
cytokines in septic patients remains controversial 
(9, 10). While a number of biomarkers have been, 
introduced but, it is not clear that measurement 
of  which  cytokine(s)  are  valuable  and  practical 
in clinical setting for prediction of outcome. The 
other important question is that which cytokine(s) 
is trustworthy for evaluation of severity of disease 
during management of illness to guide physicians 
to correct their treatments. There are several valuable 
studies  which  have  focused  to  answer  these  two 
questions. In one of very recent published article 
(11), nine biomarkers were investigated. However 
like  most  of  other  articles  published  in  this  area, 
sequential changes of biomarkers were not considered. 
For answering to second question it was required 
to  evaluate  the  level  of  sequential  changes  of 
biomarkers  in  plasma.  Based  on  this  hypothesis, 
prognostic value of the sequential plasma levels of 
the main pro-inflammatory cytokines (TNF-α, IL-
1β and IL-6) and two scoring physiological systems 
(APACHE II and SOFA) in well-documented severe 
septic patients were investigated.   
 MATERIAL  AND METHODS
Study design and setting
This was a prospective observational study which 
was conducted for 18 months in two surgico/medical 
intensive care units (ICU) of two general tutorial 
university hospitals.
Patient population
Fifty  and  one  patients  were  included  with  severe 
sepsis criteria which was defined by the American 
College of Chest Physicians/Society of Critical Care 
Medicine  Consensus  Conference  (12).  Post  CPR 
patients  and  patients  with  pre-existing  conditions 
such as liver, lung diseases and malignancy were 
excluded.  Study  protocol  was  approved  by  the 
university ethics committee.
Method
Age, sex and cause of hospitalization were recorded 157
variable was calculated as OR = eb, where b was 
the  regression  coefficient.  Receiver  operating 
characteristic (ROC) curves were used to evaluate 
the  diagnostic  value  for  cytokines  and  scoring 
systems. Values for IL-6 and TNF-α in the first 
day were log transformed to obtain proportionally 
constant  variation  and  distributed  normally. 
Statistical  analyses  were  performed  using  the 
SPSS 11.5 application (SPSS Inc., Chicago)
RESULTS
Population Characteristics
This prospective study enrolled 51 adult critically ill 
patients with criteria of severe sepsis. Of these patients, 
25 died in the ICU and 26 patients survived. Detailed 
demographic, clinical, and microbiological information 
of survivors and non-survivors summarized are in 
table 1. The differences between age and sex were not 
significant in either group. Gram negative bacteria 
were the predominant microorganisms (76%) isolated 
in 42 out of 51 patients (82%). Blood culture was 
positive for near to half of patients (49%). For 22% 
of all patients, there was not any microbial etiology 
from any collection of specimens. All patients when 
enrolled in the study were mechanically ventilated. 
The number of missing data in the day of 3 and the 
day of 7 were 8 and 15, respectively. Mortality was 
the cause of missing data. 
Scoring systems
Sequential changes in APACHE II and SOFA, two 
widespread scoring systems which were used in ICU 
are summarized in table 2. As expected, patients who 
died compared to survivors had higher APACHE II 
and SOFA scores. There were significant correlations 
between outcome with  APACHE II (day 1: r = 0.621, 
p< 0.01, day 3: r = 0.592, p<0.01, day 7: r = 0.616, 
p<0.01) and SOFA (day 1: r = 0.361, p< 0.01, day 3: 
r = 0.451, p<0.01, day 7: r = 0.466, p<0.01) scores in 
all measured days. Among cytokines, only IL-6 had 
significant correlation with both APACHE-II (day 
1: r = 0.588, p<0.01, day 7: r = 0.624, p<0.01) and 
SOFA (day 1: r = 0.533, day 3: r = 0.335, p<0.05, 
day 7: r = 0.700, p<0.01) scores.
Cytokine concentrations
The  cytokine  plasma  concentrations  of  survivors 
and nonsurvivors are shown in table 3. Cytokines 
levels in non-survivors were higher than survivors 
but in the first day, plasma level of TNF-α and IL-6 
and in other days only IL-6 level showed significant 
Table 1.  Patients’ characteristics. 
Survivors Non-survivors P Value
No. 26 25
Age (years) 46.7 ± 4.1 52.2 ± 3.7 * NS
Gender (Male/Female) 17/9 17/8 NS
Diagnose at entry:
Multiple trauma
7 5
Pneumonia 7 5
Peritonitis 2 4
Post surgical 4 2
Cerebral disorders 4 5
Others 2 4
Microbiological etiology:
Gram negative 19 13
Gram positive 3 3
Mixed gram negative/positive 1 3
Unknown 3 6
Source of infection detection:
Blood 12 13
Lung/urine/CSF 10 5
Unknown 4 7
* NS: Not significant 
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Survivors Non-survivors P Value
Day 1 
APACHE II 17.7 ± 0.9 24.5 ± 1.0 0.000
SOFA 7.1 ± 0.5 9.5 ± 0.7 0.006
Day 3
APACHE II 15.5 ± 1.1 23.1 ± 1.3 0.000
SOFA 5.8 ± 0.5 8.8 ± 0.8 0.002
Day 7 
APACHE II 14.2 ± 1.3 24.4 ± 1.7 0.000
SOFA 5.3 ± 0.5 8.9 ± 0.9 0.001
Table 2. Scoring system changes in patients.
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment. 
Table 3. Cytokines concentration.
* a Mann-Whitney rank sum test, Values are in pg/ml , IL, interleukin; TNF, tumor necrosis factor. 
Survivors Non-survivors P Value
Day 1 
TNF-α 70.1 ± 12.2 102.9 ± 15.4 0.049*
IL-6 102.9 ± 14.4 283.8 ± 40.4 0.000*
IL1-β 19.0 ± 2.3 23.9 ± 2.4 0.138
Day 3
TNF-α 69.1 ± 9.6 102.4 ± 14.3 0.051
IL-6 84.5 ± 15.2 202.9 ± 39.9 0.003
IL1-β 16.8 ± 1.4 22.1 ± 3.8 0.210
Day 7
TNF-α 67.3 ± 11.0 105.0 ± 15.2 0.054
IL-6 79.1 ± 14.9 260.3 ± 43.1 0.000
IL1-β 18.1 ± 2.1 23.0 ± 4.7 0.273
differences  between  both  groups.  There  were 
significant correlations between IL-6 and TNF-α on 
the day of 3 (r = 0.389, p<0.01) and 7 (r = 0.0349, 
p<0.05) and between IL-6 and IL-1β on the day of 
3 (r = 0.466, p<0.01). Outcome had correlation with 
IL-6 (day 1: r = 0.514, p<0.01, day 3: r = 0.506, 
p<0.01, day 7: r = 0.652, p<0.01), and TNF-α (day 
1: r = 0.278, p<0.05, day 3: r = 0.312, p<0.05, day 7: 
r = 0.329, p<0.05) in all measured days but did not 
show any significant correlation with IL-1β. There 
was no significant difference in sequential changes 
in plasma level of cytokines for IL-6 (p <0.01) and 
TNF-α (p=0.043) (Figure 1).
Predictive values of cytokines and scoring systems 
for severe sepsis mortality
Areas under ROC curves were calculated to analyze 
the  discriminative  power  of  cytokine  levels  and 
scoring systems for the prediction of severe sepsis 
mortality. The AUROC closer to 1 indicates greater 
discriminatory power, whereas an AUROC of less 
than  0.5  implies  no  diagnostic  potential.  Among 
cytokines, the highest AUC belonged to IL-6 which 
was the best predictor of mortality in all measured 
days. TNF-α had significant relation in the prediction 
of mortality but it was weaker than IL-6. IL-1β and 
did not show relation with prediction of outcome in 
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Variable AUROC (95%CI) P Value
Day 1
TNF-α 0.661 (.509-.812) 0.049
IL-6 0.797 (.675-.918) 0.000
IL-1β 0.628 (.473-.782) 0.118
APACHE II 0.858 (.752-.964) 0.000
SOFA 0.707 (.563-.851) 0.074
Day 3
TNF-α 0.684 (.521-.848) 0.043
IL-6 0.799 (.669-.928) 0.001
IL-1β 0.559 (.364-.753) 0.518
APACHE II 0.848 (.734-.936) 0.000
SOFA 0.765 (.622-.908) 0.004
Day 7
TNF-α 0.701 (.514-.889) 0.052
IL-6 0.899 (.801-.998) 0.000
IL-1β 0.552 (.312-.792) 0.615
APACHE II 0.861 (.740-.982) 0.000
SOFA 0.792 (.621-.962) 0.005
Table 4. ROC curve analysis.
AUROC,  area  under  the  receiver  operating  characteristic 
curve;    CI,  confidence  interval;  IL,  interleukin;  TNF,  tumor 
necrosis factor; APACHE, Acute Physiology and Chronic Health 
Evaluation; SOFA, Sequential Organ Failure Assessment.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figur 1 Changes in plasma concentration of TNF-Į (A), IL-1ȕ (B) and IL-6 (C) for survivors vs. 
nonsurvivors by day. Solid circles, survivors; open triangles, nonsurvivors. This figure shows that 
plasma level of log TNF-Į and log IL-6 during days are significantly higher in nonsurvivors 
(p=0.043, p<0.01). 
 
Figur 1. Changes in plasma concentration of TNF-α (A), IL-1β 
(B) and IL-6 (C) for survivors vs. nonsurvivors by day. Solid 
circles,  survivors;  open  triangles,  nonsurvivors.  This  figure 
shows that plasma level of log TNF-α and log IL-6 during days 
are significantly higher in nonsurvivors (p=0.043, p<0.01).
any time intervals (Table 4). Both of scoring systems 
showed suitable trends in the prediction of mortality 
but as shown in table 4, APACHE II was the best one 
in the prediction of outcome in the course of time. 
Variables  in  multiple  stepwise  logistic  regression 
analysis were included with backward elimination 
method to find out the fittest model and independent 
variables for prediction of mortality. The odds ratio 
is an estimate of the increase (or decrease) in the 
odds for outcome if the independent variable value 
is increased by 1. In the first day only TNF-α and 
APACHE II were introduced as a best predictors in 
final model (Table 5) but in the days of 3 and 7 IL-6 
and APACHE II independently discriminated vital 
status.  In  a  stepwise  analysis,  IL-6  was  removed 
from model of the first day in the latest step.
DISSCUTION
It has been shown that TNF-α, IL-1β and IL-6 have 
main  role  in  inflammation  caused  by  infection 
(13). Adapted to this pattern, it was also found that 
proinflammatory  cytokines  were  elevated  in  the 
plasma of septic patients. Sequential plasma levels 
of IL-6 and TNF-α elevated significantly in non-
survivors.  Many  of  the  fundamental  responses  to 
acute inflammation are mediated, in part, by TNF-α 
production which is a mediator of both innate and 
specific immunity and an important trigger for acute 
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inflammatory response. Results of this study showed 
that continuous elevated level of TNF-α makes the 
inflammation status rambunctious. Correlation among 
cytokines in the third and seventh days showed that 
they augment each other’s magnitude. In addition, 
the strong correlation between physiological scoring 
systems and outcome with cytokines in the course of 
the study proved that critical illness was associated 
with elevated level of cytokines. 
IL-6  compared  to TNF-α,  levels  was  higher  than 
baseline and more significant than TNF-α in non-
survivors during measured days and due to its stable 
kinetic in plasma, it could be justified that IL-6 is 
a  valuable  cytokine  for  prediction  of  outcome  in 
sepsis setting which is in agreement with previous 
reports (10, 14, 15). On the other hand, due to strong 
correlation of IL-6 with scoring systems in all of 
measured days, level of IL-6 is also trustworthy for 
evaluation of severity of sepsis. But in this regard, 
a few previous reported studies have not confirmed 
the mortality predictive ability of cytokines in septic 
patients (9, 16, 17). 
In agreement with other investigations, it was found 
that non-survivors did not have significant higher 
level  of  IL-1β  compared  to  survivors  (14,  17). 
However result of another study has shown that IL-
1β was higher in dead patients and it can be used as 
an early marker for outcome prediction (10). 
These finding were also evaluated and approved with 
ROC performance. Because of higher AUC of IL-6 
compared to other two cytokines in all measured 
days, IL-6 may be suggested as a suitable cytokine 
with a high discriminative power in the prediction 
of mortality during time. It has been reported that 
the  production  of  cytokines  in  response  to  stress 
varies among ethnic population, probably because 
of cytokines gene polymorphism (18). Therefore, in 
AUROC performance, we didn’t report the best cutoff 
point with ideal sensitivity and specificity for plasma 
level of cytokines. Therefore this problem seems to 
be one of the most challenging topics in the future 
of  cytokines  measurement  as  an  applied  clinical 
test. It is believed that after general agreement on a 
selected cytokine(s) for measurement in clinic, the 
cutoff point should be determined for every ethnic 
population independently with acceptable numbers 
of patients or a multi national study should be set for 
determination of an acceptable cutoff point. 
Since  APACHE  II  reflects  magnitude  of  the 
physiological  response  and  SOFA  shows  organ 
dysfunction,  using  cytokines  for  evaluation  of 
inflammatory  response  may  improve  accurate 
prediction  of  outcome.  Therefore  in  the  present 
study,  a  multiple  logistic  regression  analysis  was 
performed  to  examine  whether  any  of  cytokines 
along with scoring systems have contribution to the 
final model for mortality prediction. IL-6 showed 
stronger correlation with mortality than TNF-α in all 
measured days which was also confirmed by AUROC 
curves.  However  results  of  multivariate  analysis 
showed that TNF-α and APACHE II score in the first 
day and IL-6 in accompany with APACHE II score 
in the third and seventh days were independently 
correlated with outcome (Table 4). Although IL-6 
was removed from the model of the first day in the 
latest step of stepwise analysis (Table 5) it seems that 
IL-6 may have a potent independent relation in the 
prediction of outcome even for the first day. Some 
studies which determined independent predictors of 
outcome by performing multiple logistic regressions 
Coefficient Odds ratio (95% CI) P Value
Day 1
APACHE II 0.375 1.455 (1.177-1.799) 0.001
TNF-α 0.012 1.012 (.999-1.025) 0.061
Constant -8.883 0.000 0.000
Day 3
APACHE II 0.244 1.267 (1.080-1.508) 0.004
IL-6 0.009 1.009 (1.001-1.018) 0.033
Constant -6.474 0.002 0.001
Day 7
APACHE II 0.187 1.206 (.988-1.471) 0.065
IL-6 0.012 1.012 (1.001-1.024) 0.036
Constant -6.041 0.002 0.008
Table  5.  Final  models  built  using  stepwise  logistic  regression  to  predict  mortality  during  cytokines  and  scoring  systems  measured  days.
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; IL, interleukin; TNF, tumor 
necrosis factor; CI, confidence interval.
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and included TNF-α, IL-1β and IL-6 as measured 
cytokines,  have  introduced  IL-6  as  independent 
factors  (15,  19).  Procalcitonin  (PCT),  a  protein 
with identical sequence as the precursor protein of 
the human calcitonin hormone, is a new diagnostic 
parameter  of  bacterial  infection  and  systemic 
inflammation. High plasma concentrations of PCT 
have been found in patients with severe bacterial and 
fungal infections, in sepsis and in patients suffering 
from multi organ dysfunction syndrome (MODS). 
Several  clinical  studies  aimed  to  establish  the 
usefulness of PCT to confirm the diagnosis and to 
predict outcome of septic patients (20). 
Thus, for future studies, measurements of plasma 
PCT concentrations may be a helpful approach to 
improve  the  outcome  prediction  in  patients  with 
severe sepsis particularly when combined with the 
APACHE II scoring system and IL-6 measurement. 
Other  than  sepsis,  a  number  of  etiologies  cause 
inflammation  in  critically  ill  patients.  While 
specificity  in  correct  diagnosis  is  important, 
sensitivity to monitor treatment sufficiency is also 
critical. It seems that finding of biomarker with high 
specificity and sensitivity will have a strategic role 
in management of septic patient. 
CONCLUSION
Measurement of TNF-α and IL-6 at the early phase of 
sepsis may be helpful to evaluate severity of disease 
and to estimate outcome. Plasma level of IL-6 can 
be measured to monitor treatment sufficiency. It is 
believed  that  combination  of  these  two  cytokines 
with  APACHE  II  score  is  valuable  indicator  in 
management of septic patients. 
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